Drug Discovery
By
Can GenepoweRx and MGI Tech’s AI-Driven Genomic Partnership Transform Personalized Medicine in 2025?
Key Highlights: Strategic Alliance to Revolutionize Genomic MedicineIndian AI-driven startup GenepoweRx and China’s MGI Tech have joined forces…
Bexorg and Biohaven: Can Their AI-Driven Whole-Brain Discovery Platform Revolutionize CNS Drug Development?
Key Highlights: Strategic Collaboration to Transform CNS TherapeuticsBexorg, a techbio innovator focused on decoding the human brain, has…
Tevogen AI & Microsoft: Will Their AI & Generics Bet—and $10B Asset Strategy—Redefine U.S. Bioinnovation Infrastructure?
Key Highlights HQ Expansion to Power AI, Generics & Biosimilar VisionTevogen Bio Holdings Inc. (Nasdaq: TVGN) has more…
AlphaMeld AI and VedTechBio: Can Their AI Alliance Cut Discovery Timelines by 50% Across 3 Liver & Metabolic Programs?
Key Highlights Strategic Alliance to Bridge AI Discovery and Translational ExecutionAlphaMeld Corporation, a global leader in AI-native drug…
Could Everest Medicines’ AI-Powered mRNA Platform Signal a Turning Point for Cancer and Autoimmune Therapies in Asia?
Key Highlights Reimagining Cancer Vaccines with AI-Optimized PersonalizationAt the 2025 Everest Medicines R&D Day, the company showcased EVM16,…
Shift Bioscience Unveils AI Framework to Improve Gene Target Discovery for Rejuvenation Therapies
Key Highlights Deeper DiveCambridge-based Shift Bioscience is rethinking how AI models are evaluated for rejuvenation research. Their study,…
